4.4 Article

Trends in opioid utilization in Hungary, 2006-2020: A nationwide retrospective study with multiple metrics

期刊

EUROPEAN JOURNAL OF PAIN
卷 26, 期 9, 页码 1896-1909

出版社

WILEY
DOI: 10.1002/ejp.2011

关键词

-

资金

  1. National Research, Development and Innovation Fund [TKP2021--EGA]

向作者/读者索取更多资源

This study analyzed the utilization of opioids in ambulatory care in Hungary from 2006 to 2020. The study found that the overall utilization of opioids increased during this period, driven by an increase in both weak and strong opioids. Tramadol was the most commonly used opioid, and oral administration was the dominant route of administration. The study also revealed an increase in opioid use for musculoskeletal pain and a significant decline in opioid use for cancer pain.
Background Opioid use is well documented in several countries: some countries struggle with overuse, whereas others have almost no access to opioids. For Europe, limited data are available. This study analysed Hungarian opioid utilization in ambulatory care between 2006 and 2020. Methods We obtained national drug utilization data on reimbursed opioid analgesics (ATC code: N02A) from a national health insurance database for a 15-year period. We investigated utilization trends, using three volume-based metrics [defined daily dose per 1000 inhabitants per day (DID), oral morphine equivalent per 1000 inhabitants per day, packages dispensed per 1000 inhabitants per year]. We stratified data based on administration routes, analgesic potency and reimbursement categories. Results Total opioid utilization increased during the study period according to all three metrics (74% in DID) and reached 5.31 DID by 2020. Upward trends were driven by an increase both in weak and strong opioid use (79% vs. 53%). The most commonly used opioids were fentanyl (in the strong category; 0.76 DID in 2020) and tramadol (in the weak category; 2.62 DID in 2020). Overall, tramadol was also the most commonly used opioid throughout the study period. Oral administration of opioid medications was dominant. Based on reimbursement categories, musculoskeletal pain was becoming a more frequent indication for opioid use (1552% increase in DID), while opioid use for cancer pain declined significantly during the study period (-33% in DID). Conclusions Our low utilization numbers might indicate underuse of opioid analgesia, especially for cancer pain. Significance This study was one of the recent opioid utilization studies using three volume-based metrics, covering a long time period. To our knowledge, this was also the first national, population level study describing opioid utilization in Hungary. National opioid utilization data suggested not an overuse but rather an underuse of opioid analgesics in a developed, Central European country.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据